Drugs / Jia Shen Tablets
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06348498 | Apr 2024 → Jun 2026 | heart failure | Tasly Pharmaceutical Group Co., Ltd | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Jia Shen Tablets | “Jia Shen Tablets are oral, compound traditional chinese medicine.” NCT06348498 ↗ |
| Known as | Jia Shen Tablet | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06348498 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “Jia Shen Tablets are oral, compound traditional chinese medicine.” NCT06348498 ↗ |
| Route | Oral | “take orally” NCT06348498 ↗ |